Additionally, PGD2-mediated metabolites could remodel the TME and inhibit the migration of inflammatory cells such as neutrophils and macrophages, thereby enhancing the anti-tumor immune response and facilitating tumor treatment. Here, PTGDS is linked to neoplasm.